FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer
FT-6876 是一种强效且选择性的 CBP/p300 抑制剂，在雄激素受体阳性乳腺癌的临床前模型中具有活性
期刊:Targeted Oncology
影响因子:4.4
doi:10.1007/s11523-023-00949-7
Maureen Caligiuri, Grace L Williams, Jennifer Castro, Linda Battalagine, Erik Wilker, Lili Yao, Shawn Schiller, Angela Toms, Ping Li, Eneida Pardo, Bradford Graves, Joey Azofeifa, Agustin Chicas, Torsten Herbertz, Maria Lai, Joel Basken, Kenneth W Wood, Qunli Xu, Sylvie M Guichard
